R&D

Structure-activity relationship (SAR) by NMR is a technique developed in 1996 by Stephen Fesik at Abbot Laboratories. SAR by NMR is the first experimental demonstration of the fragment-based approach to drug discovery. The method uses NMR spectroscopy to probe the surface area surrounding a protein’s active site for ligand binders. A small, structurally diverse chemical library is screened by NMR with the goal of identifying ligands that bind proximal to each other in the protein’s active site.

Our scientist are rigorously committed to solving real life problems: neurodegeneration, diabetes, and cancer fully utilizing our specialty.